ONTO · Onto Innovation
AI read · Neutral
The AI's read
This is an analyst's view, not a report of new sales, profits, or company plans. The story gives no new business facts to show that Onto Innovation has changed.
Oppenheimer kept its Buy rating and $450 price target. The story reports no new company results or plans, so it does not change Onto Innovation's outlook.
This is an analyst's view, not a report of new sales, profits, or company plans. The story gives no new business facts to show that Onto Innovation has changed.
Follow Onto Innovation (ONTO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ONTO